Patent SG-11201908539V-A (SG)
Title: Auto-injector
Inventor: ARNOTT RACHEL
IPC: A61M5/142
Filed: 2018-05-04
Abstract: FIG. 8 241 240 242 344 300 J 340 0 322 r- 362- 360 40 306 324 (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 08 November 2018 (08.11.2018) WIP0 I Iiiimmolionsonomitimmomomilioniovois (10) International Publication Number WO 2018/204779 Al PCT 1-1 O\ N N O 71- 00 O O 1-1 (51) International Patent Classification: A61M 5/20 (2006.01) A61M 5/142 (2006.01) (21) International Application Number: PCT/US2018/031077 (22) International Filing Date: 04 May 2018 (04.05.2018) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/502,278 05 May 2017 (05.05.2017) US (71) Applicant: REGENERON PHARMACEUTICALS, INC. [US/US]; 777 Old Saw Mill River Road, Tarrytown, NY 10591 (US). (72) Inventors: ARNOTT, Rachel; 249 Pierce Street, San Fran- cisco, CA 94117 (US). BARTON, Scott; c/o Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarry- town, NY 10591 (US). BURGESS, Bart, E.; c/o Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tar- rytown, NY 10591 (US). GILDERSLEEVE, Richard; c/ o Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill Riv- er Road, Tarrytown, NY 10591 (US). GORALTCHOUK, Alexei; c/o Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591 (US). GRYGUS, Bryan, C.; c/o Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591 (US). HAL- BIG, Daniel; c/o Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591 (US). KANEL, Christopher; c/o Regeneron Pharmaceuticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591 (US). LANGLEY, Trevor; c/o Regeneron Pharmaceuti- cals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591 (US). MARINO, Alfred; c/o Regeneron Pharmaceu- ticals, Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591 (US). (74) Agent: MA, Jameson; Bookoff McAndrews, PLLC, 2020 K Street, NW, Suite 400, Washington, DC 20006 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (54) Title: AUTO-INJECTOR (57) : An injection device includes a carrier, a needle, a driver coupled to the needle, the driver being slidable relative to the carrier between a retracted configuration and a deployed configuration, a shuttle configured to move the driver between the retracted configuration and the deployed configuration, and a stop configured to move from a first configuration to a second configuration, wherein the stop is configured to maintain the driver in the deployed configuration, and movement of the stop from the first configuration to the second configuration allows the shuttle to move the driver from the deployed configuration to the retracted configuration. [Continued on next page] WO 2018/204779 Al IMEDIM0110101011M0H100101011110BECHIMIO#011# SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: of inventorship (Rule 4.17(iv)) Published: with international search report (Art. 21(3)) before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h))